Clinical Trial Update: A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3, multicenter, open-label randomized crossover trial completed to compare subject preference for Kemstro (baclofen) versus conventional baclofen tablets …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BACLOFEN (Baclofen)
• Kemstro (baclofen)

Snippet

Sponsor: UCB Pharma | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED